» Articles » PMID: 3689982

Prognostic Factors for Recurrence and Survival in Human Breast Cancer

Overview
Specialty Oncology
Date 1987 Oct 1
PMID 3689982
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Since only about half of primary breast cancer patients are cured by local treatment, factors which can predict which patients are likely to recur and should thus receive preventive treatment are needed. Here, work on such prognostic factors which has been going on in San Antonio for many years will be reviewed. The significance of the number of involved axillary nodes and of steroid receptors is already well known, while the value of tumor proliferative rate and ploidy has been appreciated more recently, and the significance of amplification of the oncogene HER-2/neu is just now emerging.

Citing Articles

Lymph Nodes as Anti-Tumor Immunotherapeutic Tools: Intranodal-Tumor-Specific Antigen-Pulsed Dendritic Cell Vaccine Immunotherapy.

Morisaki T, Morisaki T, Kubo M, Morisaki S, Nakamura Y, Onishi H Cancers (Basel). 2022; 14(10).

PMID: 35626042 PMC: 9140043. DOI: 10.3390/cancers14102438.


A nomogram constructed using intraoperative ex vivo shear-wave elastography precisely predicts metastasis of sentinel lymph nodes in breast cancer.

Bae S, Youk J, Yoon C, Park S, Cha C, Lee H Eur Radiol. 2019; 30(2):789-797.

PMID: 31696293 PMC: 6957551. DOI: 10.1007/s00330-019-06473-5.


Tumor Microenvironment of Metastasis (TMEM) Doorways Are Restricted to the Blood Vessel Endothelium in Both Primary Breast Cancers and Their Lymph Node Metastases.

Ginter P, Karagiannis G, Entenberg D, Lin Y, Condeelis J, Jones J Cancers (Basel). 2019; 11(10).

PMID: 31597373 PMC: 6827388. DOI: 10.3390/cancers11101507.


Origins of lymphatic and distant metastases in human colorectal cancer.

Naxerova K, Reiter J, Brachtel E, Lennerz J, van de Wetering M, Rowan A Science. 2017; 357(6346):55-60.

PMID: 28684519 PMC: 5536201. DOI: 10.1126/science.aai8515.


Lymphovascular invasion and histologic grade are associated with specific genomic profiles in invasive carcinomas of the breast.

Fidalgo F, Rodrigues T, Pinilla M, Silva A, Maciel M, Rosenberg C Tumour Biol. 2014; 36(3):1835-48.

PMID: 25391423 PMC: 4375298. DOI: 10.1007/s13277-014-2786-z.


References
1.
Meyer J . Cell kinetics in selection and stratification of patients for adjuvant therapy of breast carcinoma. NCI Monogr. 1986; (1):25-8. View

2.
Slamon D, Clark G, Wong S, Levin W, Ullrich A, McGuire W . Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987; 235(4785):177-82. DOI: 10.1126/science.3798106. View

3.
McGuire W, Meyer J, Barlogie B, Kute T . Impact of flow cytometry on predicting recurrence and survival in breast cancer patients. Breast Cancer Res Treat. 1985; 5(2):117-28. DOI: 10.1007/BF01805985. View

4.
McGuire W, Dressler L . Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients. J Natl Cancer Inst. 1985; 75(3):405-10. View

5.
Clark G, McGuire W, HUBAY C, Pearson O, Marshall J . Progesterone receptors as a prognostic factor in Stage II breast cancer. N Engl J Med. 1983; 309(22):1343-7. DOI: 10.1056/nejm198312013092240. View